Spark Therapeutics (ONCE) Misses Q1 EPS by 11c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Spark Therapeutics (ONCE) Misses Q1 EPS by 11c
May 4, 2016 7:29 AM EDT
Company makes progress across multiple programs
Appoints Daniel R. Faga as Chief Business Officer
PHILADELPHIA, May 04, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE) today announced financial results for the quarter ended March 31, 2016 and updated investors on its progress.
During the last few months we have continued to make progress across our portfolio of gene therapy candidates targeting the eye, liver and the central nervous system, said Jeffrey D. Marrazzo, co-founder and chief executive officer... More
May 3, 2016 5:15 PM EDT
PHILADELPHIA, May 03, 2016 (GLOBE NEWSWIRE) -- Spark Therapeutics (NASDAQ: ONCE) today announced that members of its management team will participate in three upcoming conferences in May:
Deutsche Bank 41st Annual Healthcare Conference on Wednesday, May 4, 2016, at 8:00 a.m. at The InterContinental, Boston  Piper Jaffray GenomeRX Symposium on Tuesday, May 17, 2016, at The...
More
